Immunic Inc. (IMUX)
NASDAQ: IMUX
· Real-Time Price · USD
0.80
-0.02 (-1.95%)
At close: Oct 17, 2025, 3:59 PM
0.82
2.46%
After-hours: Oct 17, 2025, 05:17 PM EDT
Immunic Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | n/a | n/a | n/a | n/a |
Cost of Revenue | 134K | 111K | 77K | 85K |
Gross Profit | -134K | -111K | -77K | -85K |
Operating Income | -98.05M | -99.22M | -119.49M | -91.67M |
Interest Income | 3.39M | 3.08M | 1.04M | 66K |
Pretax Income | -100.51M | -93.61M | -120.41M | -92.94M |
Net Income | -100.51M | -93.61M | -120.41M | -92.79M |
Selling & General & Admin | 18.01M | 16.01M | 15.26M | 13.3M |
Research & Development | 80.05M | 83.22M | 71.25M | 61.12M |
Other Expenses | n/a | n/a | n/a | 17.25M |
Operating Expenses | 98.05M | 99.22M | 86.52M | 91.67M |
Interest Expense | n/a | n/a | 1.04M | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 98.05M | 99.22M | 86.52M | 91.67M |
Income Tax Expense | n/a | n/a | 33.89M | -151K |
Shares Outstanding (Basic) | 100.17M | 44.32M | 31.82M | 23.65M |
Shares Outstanding (Diluted) | 100.17M | 44.32M | 31.82M | 23.65M |
EPS (Basic) | -1 | -2.11 | -3.78 | -3.92 |
EPS (Diluted) | -1 | -2.11 | -3.78 | -3.92 |
EBITDA | -100.37M | -99.11M | -120.33M | -92.86M |
EBIT | -100.51M | -99.22M | -120.41M | -92.94M |
Depreciation & Amortization | 134K | 111K | 77K | 85K |
Source: Financial Modeling Prep. Financial Sources.